Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

YM 022 MeSH Supplementary Concept Data 2025


MeSH Supplementary
YM 022
Unique ID
C087260
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C087260
Entry Term(s)
1-(2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-3-(3-methylphenyl)urea
YM-022
YM022
Pharm Action
Hormone Antagonists
Registry Numbers
145084-28-2
CAS Type 1 Name
Urea, N-(2,3-dihydro-1-(2-(2-methylphenyl)-2-oxoethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(3-methylphenyl)-, (R)-
Heading Mapped to
*Benzodiazepines
Frequency
65
Note
a potent and selective gastrin/cholecystokinin-B receptor antagonist; structure given in first source
Source
J Pharmacol Exp ther 1994 May;269(2):725-31
Date of Entry
1994/06/15
Revision Date
2000/09/29
YM 022 Preferred
1-(2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-3-(3-methylphenyl)urea Broader
page delivered in 0.005s